Model-Informed Decision Making from Drug Discovery to Reimbursement: A Roadmap for Clinical Pharmacology in Value-Based Healthcare
Academic source · The Journal of Clinical Pharmacology
Source published: · Event / reporting date: 2026-08-20
Site published: 2026-11-04 · Updated: 2026-11-04
This source is linked automatically. Choose a question to get started.
What the paper reports
This commentary proposes a lifecycle approach to model-informed decision-making, from discovery and dose selection to regulatory evaluation and reimbursement. It discusses quantitative methods, patient-relevant outcomes, and real-world data, alongside challenges in integration, transparency, and stakeholder acceptance. It is a conceptual roadmap, not a prospective validation of one modeling strategy.
Why this paper is included
Helps frame modeling around decisions and the evidence needed to support them.
The interpretation above is analysis, not a conclusion attributed to the original source.
Read the original source ↗Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections